Literature DB >> 27708949

Differential diagnosis of elevated erythrocyte sedimentation rate and C-reactive protein levels: a rheumatology perspective.

Berivan Bitik1, Rıdvan Mercan1, Abdurrahman Tufan1, Engin Tezcan1, Hamit Küçük1, Mustafa İlhan2, Mehmet Akif Öztürk1, Seminur Haznedaroğlu1, Berna Göker1.   

Abstract

OBJECTIVE: In the case of high erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels, the diagnosis of the underlying disease can be challenging especially in serologically unrevealing patients who have nonspecific clinical findings. We aimed to investigate the final distribution of definitive diagnoses in patients who initially presented with nonspecific clinical findings and sustained elevations in serum ESR/CRP levels.
MATERIAL AND METHODS: The medical records of patients hospitalized in a rheumatology clinic between January 2010 and January 2011 were retrospectively analyzed. The patients were classified into two main groups: those with previously diagnosed underlying rheumatic disease (RD) and those without. The groups were analyzed for the final distribution of definitive diagnoses.
RESULTS: Out of 112 patients in the general study population, 47 had a previous RD and 65 had no previous history of RD. In these 65 patients, the most common etiology of nonspecific elevations in ESR/CRP levels was new onset RD (52.3%). Polymyalgia rheumatica (PMR) was the most common new onset RD (38% of all new onset RD) followed by seronegative rheumatoid arthritis. The incidences of infections and malignancies were 24.6% and 9.2%, respectively. CRP levels were significantly higher in infections when compared with new onset RD or malignancies (p<0.05). In patients with previous RD, the flare of the underlying disease was the most common etiology of nonspecific elevations in ESR/CRP levels (n=39, 83%, 20 female/19 male).
CONCLUSION: Extraordinarily high levels of serum CRP in a patient with nonspecific clinical findings should raise suspicion for non-rheumatic diagnoses, such as infection and malignancy, even in the presence of a previously diagnosed RD. Advanced radiological investigation is justified in these cases to rule out malignancy.

Entities:  

Keywords:  Blood sedimentation; C-reactive protein; rheumatology

Year:  2015        PMID: 27708949      PMCID: PMC5047224          DOI: 10.5152/eurjrheum.2015.0113

Source DB:  PubMed          Journal:  Eur J Rheumatol        ISSN: 2147-9720


  8 in total

Review 1.  Low back pain.

Authors:  R A Deyo; J N Weinstein
Journal:  N Engl J Med       Date:  2001-02-01       Impact factor: 91.245

Review 2.  Polymyalgia rheumatica with normal erythrocyte sedimentation rate: clinical aspects.

Authors:  V M Martínez-Taboada; R Blanco; V Rodríguez-Valverde
Journal:  Clin Exp Rheumatol       Date:  2000 Jul-Aug       Impact factor: 4.473

3.  The story behind the acute-phase reactants.

Authors:  Luis M Amezcua-Guerra; Diana Castillo-Martinez; Rafael Bojalil
Journal:  J Rheumatol       Date:  2010-02       Impact factor: 4.666

Review 4.  Polymyalgia rheumatica.

Authors:  Tanaz A Kermani; Kenneth J Warrington
Journal:  Lancet       Date:  2012-10-08       Impact factor: 79.321

5.  Serum C-reactive protein levels in disease.

Authors:  J J Morley; I Kushner
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

6.  Extremely elevated C-reactive protein.

Authors:  Steven Vanderschueren; Dries Deeren; Daniël C Knockaert; Herman Bobbaers; Xavier Bossuyt; Willy Peetermans
Journal:  Eur J Intern Med       Date:  2006-10       Impact factor: 4.487

7.  The Assessment in Spondyloarthritis International Society (ASAS) classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general: the spondyloarthritis concept in progress.

Authors:  Henning Zeidler; Bernard Amor
Journal:  Ann Rheum Dis       Date:  2011-01       Impact factor: 19.103

8.  Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications.

Authors:  E M Macy; T E Hayes; R P Tracy
Journal:  Clin Chem       Date:  1997-01       Impact factor: 8.327

  8 in total
  7 in total

Review 1.  Relapse of polymyalgia rheumatica following adjuvanted influenza vaccine: A case-based review.

Authors:  Margaret F Bassendine; Simon H Bridge
Journal:  Eur J Rheumatol       Date:  2019-12-16

2.  Giant Cell Arteritis among Fevers of Unknown Origin (FUO): An Atypical Presentation.

Authors:  Lorenzo Grazioli-Gauthier; Natalie Marcoli; Gianluca Vanini; Enos Bernasconi; Dea Degabriel
Journal:  Eur J Case Rep Intern Med       Date:  2021-02-09

Review 3.  Red Blood Cells: Chasing Interactions.

Authors:  Virginia Pretini; Mischa H Koenen; Lars Kaestner; Marcel H A M Fens; Raymond M Schiffelers; Marije Bartels; Richard Van Wijk
Journal:  Front Physiol       Date:  2019-07-31       Impact factor: 4.566

4.  Helicobacter canis bacteraemia in a rheumatoid arthritis patient treated with tofacitinib: case report and literature review.

Authors:  Matic Mihevc; Metka Koren Krajnc; Maja Bombek Ihan; Iztok Holc
Journal:  Ann Clin Microbiol Antimicrob       Date:  2021-04-08       Impact factor: 3.944

5.  A Practical Guide to Managing Patients With Systemic Symptoms and Breast Implants.

Authors:  Patricia McGuire; Daniel J Clauw; Jason Hammer; Melinda Haws; William P Adams
Journal:  Aesthet Surg J       Date:  2022-03-15       Impact factor: 4.283

6.  A systematic review on time trend incidence of rheumatoid arthritis in outpatient rheumatology clinics.

Authors:  E T A M van Delft; Maha Jamal; Hannah den Braanker; T M Kuijper; J M W Hazes; Deirisa Lopes Barreto; A E A M Weel-Koenders
Journal:  Front Med (Lausanne)       Date:  2022-08-24

7.  Distinguishing rheumatoid arthritis from psoriatic arthritis.

Authors:  Joseph F Merola; Luis R Espinoza; Roy Fleischmann
Journal:  RMD Open       Date:  2018-08-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.